Cerecor Inc.
also invests · investor profileFounded 2011 · 1 known investors
Avalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1β antibody.
BiotechMedical Devices
Investors · 1
Frequently asked questions
- What does Cerecor Inc. do?
- Avalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1β antibody.
- Who are Cerecor Inc.'s investors?
- Cerecor Inc.'s investors include OrbiMed.